11
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Prostate cancer intervention

Involving the patient in early detection and treatment

, MD, MPH & , PhD
Pages 43-49 | Published online: 30 Jun 2015
 

PREVIEW

Prostate cancer is the most common malignancy diagnosed in men. Screening by prostate-specific antigen (PSA) testing is widespread in the United States, and treatment recommendations often urge early therapy. Yet there is ongoing controversy about patient care because of a lack of evidence demonstrating that such an aggressive approach improves the length and quality of a man's life. Drs Wilt and Partin review the epidemiologic factors of prostate cancer and discuss the research findings, recommendations, and pros and cons of screening and therapy. Further, they make a case that rather than routinely ordering a PSA test for all men, physicians should inform patients about the potential but uncertain benefits and the possible harm of screening and treatment and then incorporate patient preferences into decision making.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.